LGND
Ligand Pharmaceuticals Inc.
stockNASDAQ
At CloseOct 30, 2026 4:03:30 PM EDT
324.00USD+2.102%(+6.67)344,311
Pre-marketOct 30, 2026 10:29:56 AM EDT
319.05USD+0.542%(+1.72)
LGND Financials
In Q3 FY 2026 (ended ), Ligand Pharmaceuticals Inc. (LGND) reported revenue of $78.75M, net income of −$28.49M, operating cash flow of −$27.59M, and assets of $2.24B.
Loading financial statements…